ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Eases Some Cooperative Group Concern; DeVita Considers Other CCOP- Research Base Funding Option

April 2, 1982

NCI Drug Development Program Produced 7 Drugs In 10 Years, Chabner Tells Group

February 3, 1995

Report Urges NCI: No Unfunded Mandates for Cancer Centers

October 18, 1996

NCI to Ask Cancer Panel, NCAB, to Help Respond To Request for Review Of National Cancer Program

December 4, 1992

ACS Study Finds Low Tar Cigarettes Cause Few Lung Abnormalities

March 2, 1979

NTP Panel Completed To Write New Testing, Evolution Guidelines

April 22, 1983